Cardium Therapeutics, Inc.
Cardium Therapeutics, Inc. (CXM) is a publicly traded company in the Unknown sector. Across all available filings, 48 corporate insiders have executed 511 transactions totaling $473.7M, demonstrating a bearish sentiment with -$25.5M in net insider flow. The most recent transaction on Dec 16, 2025 involved a sale of 9,099 shares valued at $70.8K.
CXM Insider Activity Summary
Who Is Buying CXM Stock?
No significant insider buying has been recorded for CXM in the recent period.
Who Is Selling CXM Stock?
No significant insider selling has been recorded for CXM in the recent period.
Is Cardium Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CXM is bearish with an Insider Alignment Score of 47/100 and a net flow of -$25.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CXM Frequently Asked Questions
Understanding CXM Insider Activity
Insider trading at Cardium Therapeutics, Inc. (CXM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 48 insiders are actively trading CXM stock, having executed 511 transactions in the past 90 days. The most active insider is Corporate Investors Ix, Ltd. H&f (Executive), who has made 2 transactions totaling $139.7M.
Related Tools
Track Cardium Therapeutics, Inc. Insider Activity
Get notified when executives and directors at CXM file new Form 4 transactions